Inflammatory Bowel Disease Treatment Market Scope And Analysis

  • Report Code : TIPRE00003491
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi di mercato, quota e statistiche del trattamento delle malattie infiammatorie intestinali entro il 2031

Buy Now

Inflammatory Bowel Disease Treatment Market Report Inflammatory Bowel Disease Treatment Market Size and Share Inflammatory Bowel Disease Treatment Market Scope and Analysis

Inflammatory Bowel Disease Treatment Market Report Scope

Report Attribute Details
Market size in 2023 US$ 24.05 Billion
Market Size by 2031 US$ 31.67 Billion
Global CAGR (2023 - 2031) 3.50%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Classe di farmaci
  • aminosaliciclati
  • immunomodulatori
  • inibitori del TNF
  • corticosteroidi
By Indicazione
  • morbo di Crohn
  • colite ulcerosa
By Canale di distribuzione
  • farmacia ospedaliera
  • farmacia online
  • farmacia al dettaglio
By Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
Regions and Countries Covered Nord America
  • Stati Uniti
  • Canada
  • Messico
Europa
  • Regno Unito
  • Germania
  • Francia
  • Russia
  • Italia
  • Resto Europa
Asia-Pacifico
  • Cina
  • India
  • Giappone
  • Australia
  • resto delAsia-Pacifico
America centrale e meridionale
  • Brasile
  • Argentina
  • Resto delAmerica Centrale e Meridionale
Medio Oriente e Africa
  • Sudafrica
  • Arabia Saudita
  • Emirati Arabi Uniti
  • Resto del Medio Oriente e Africa
Market leaders and key company profiles
  • Pfizer, Inc.,
  • Novartis AG,
  • AbbVie, Inc.,
  • Takeda Pharmaceuticals, Johnson and Johnson
  • , Celegene Corporation,
  • Bausch Health Companies
  • , UCB, Inc.
  • Cosmo Pharmaceutic``als
    		•